- Home
- AGMH vs CNSP Comparison
AGMH vs CNSP Comparison
Compare AGMH & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGMH | CNSP |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1M | 2.1M |
| IPO Year | 2017 | 2019 |
Fundamental Metrics
Financial Performance| Metric | AGMH | CNSP |
|---|---|---|
| Price | $0.91 | $2.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | ★ 117.2K | 26.9K |
| Earning Date | 05-12-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.07 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.03 | $0.73 |
| 52 Week High | $18.10 | $10.59 |
Technical Indicators
Market Signals| Indicator | AGMH | CNSP |
|---|---|---|
| Relative Strength Index (RSI) | 36.59 | 50.09 |
| Support Level | $0.83 | $2.06 |
| Resistance Level | $1.36 | $3.00 |
| Average True Range (ATR) | 0.11 | 0.27 |
| MACD | 0.02 | 0.08 |
| Stochastic Oscillator | 13.68 | 58.51 |
Price Performance
Historical ComparisonAbout AGMH AGM Group Holdings Inc.
AGM Group Holdings Inc is an integrated technology company. The company focuses on blockchain-oriented ASIC chip design, high-end crypto miner production, and fintech technology software services. The company generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.